Literature DB >> 25241182

Parental military service, agent orange exposure, and the risk of rhabdomyosarcoma in offspring.

Seymour Grufferman1, Philip J Lupo2, Rachel Isaksson Vogel3, Heather E Danysh4, Erik B Erhardt5, Simona Ognjanovic6.   

Abstract

OBJECTIVE: To evaluate the role of parental military service-related exposures and rhabdomyosarcoma (RMS) risk in offspring using data from a large case-control study of childhood RMS. STUDY
DESIGN: Cases (n = 319) were enrolled from the third trial run by the Intergroup Rhabdomyosarcoma Study Group. Population-based controls (n = 319) were pair-matched to cases on race, sex, and age. Conditional logistic regression was used to evaluate parental military service-related exposures and their associations with childhood RMS by generating aORs and 95% CIs. Statistical significance was defined as P < .05.
RESULTS: There were no significant associations between parental military service and childhood RMS. The strongest association was with maternal military service; however, this association was attenuated and did not remain significant after adjusting for covariates (aOR = 2.75, 95% CI 0.71, 10.62). An elevated effect estimate was found when assessing paternal exposure to Agent Orange (AO) and childhood RMS but was not statistically significant (aOR = 1.72, 95% CI 0.55, 5.41).
CONCLUSIONS: We found little evidence that parental military service of AO exposure influences the risk of RMS in offspring. These findings are notable in light of the continuing controversies surrounding the intergenerational effects of AO exposure.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25241182      PMCID: PMC4254119          DOI: 10.1016/j.jpeds.2014.08.009

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Evidence of recall bias in volunteered vs. prompted responses about occupational exposures.

Authors:  K Teschke; J C Smith; A F Olshan
Journal:  Am J Ind Med       Date:  2000-10       Impact factor: 2.214

2.  Agent Orange no longer linked to childhood AML.

Authors:  Khabir Ahmad
Journal:  Lancet Oncol       Date:  2002-04       Impact factor: 41.316

Review 3.  Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.

Authors:  Simona Ognjanovic; Magali Olivier; Tracy L Bergemann; Pierre Hainaut
Journal:  Cancer       Date:  2011-08-11       Impact factor: 6.860

4.  Secular trends in response rates for controls selected by random digit dialing in childhood cancer studies: a report from the Children's Oncology Group.

Authors:  Greta R Bunin; Logan G Spector; Andrew F Olshan; Leslie L Robison; Michelle Roesler; Seymour Grufferman; Xiao-ou Shu; Julie A Ross
Journal:  Am J Epidemiol       Date:  2007-04-23       Impact factor: 4.897

5.  Paternal exposure to Agent Orange and spina bifida: a meta-analysis.

Authors:  Anh Duc Ngo; Richard Taylor; Christine L Roberts
Journal:  Eur J Epidemiol       Date:  2009-11-06       Impact factor: 8.082

6.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

7.  Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: a report from the Children's Oncology Group.

Authors:  Philip J Lupo; Renke Zhou; Stephen X Skapek; Douglas S Hawkins; Logan G Spector; Michael E Scheurer; M Fatih Okcu; Beatrice Melin; Karin Papworth; Erik B Erhardt; Seymour Grufferman
Journal:  Int J Cancer       Date:  2013-08-01       Impact factor: 7.396

Review 8.  Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas.

Authors:  Douglas S Hawkins; Sheri L Spunt; Stephen X Skapek
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

9.  Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype.

Authors:  S Ognjanovic; S E Carozza; E J Chow; E E Fox; S Horel; C C McLaughlin; B A Mueller; S Puumala; P Reynolds; J Von Behren; L Spector
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

10.  Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects.

Authors:  P Yang; S Grufferman; M J Khoury; A G Schwartz; J Kowalski; F B Ruymann; H M Maurer
Journal:  Genet Epidemiol       Date:  1995       Impact factor: 2.135

View more
  3 in total

1.  Efficacy of a first course of Ibuprofen for patent ductus arteriosus closure in extremely preterm newborns according to their gestational age-specific Z-score for birth weight.

Authors:  Doriane Madeleneau; Marie-Stephanie Aubelle; Charlotte Pierron; Emmanuel Lopez; Juliana Patkai; Jean-Christophe Roze; Pierre-Henri Jarreau; Geraldine Gascoin
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

2.  An investigation of cancer rates in the Argentia region, Newfoundland and Labrador: an ecological study.

Authors:  Pauline Duke; Marshall Godwin; Mandy Peach; Jacqueline Fortier; Stephen Bornstein; Sharon Buehler; Farah McCrate; Andrea Pike; Peizhong Peter Wang; Richard M Cullen
Journal:  J Environ Public Health       Date:  2015-11-08

Review 3.  Pediatric Rhabdomyosarcoma: Epidemiology and Genetic Susceptibility.

Authors:  Bailey A Martin-Giacalone; P Adam Weinstein; Sharon E Plon; Philip J Lupo
Journal:  J Clin Med       Date:  2021-05-09       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.